Treatment of pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in children

Pediatr Infect Dis J. 2013 Apr;32(4):417-9. doi: 10.1097/INF.0b013e318284b1e8.

Abstract

Fifty-four children were diagnosed as pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriaceae at the largest children's hospital in Japan. Although 32 (59%) patients were treated with antimicrobials that are ineffective against the organisms, 39 (72%) patients became afebrile ≤2 days and clinical outcome was excellent. Children with pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriaceae can be successfully treated with noncarbapenem antimicrobials.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Enterobacteriaceae / drug effects
  • Enterobacteriaceae / enzymology*
  • Enterobacteriaceae Infections / drug therapy*
  • Enterobacteriaceae Infections / microbiology*
  • Female
  • Humans
  • Japan
  • Male
  • Pyelonephritis / drug therapy*
  • Pyelonephritis / microbiology*
  • Treatment Outcome
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases